|
End-of-day quote
Shenzhen S.E.
26/10/2026
|
5-day change | 1st Jan Change | ||
| 7.700 CNY | -0.26% |
|
-4.23% | -10.88% |
| Market Cap | 3.93B 589M 527M 488M 441M 826M 56.07B 840M 5.87B 2.32B 29.33B 2.21B 2.16B 92.85B | P/E 2024 |
65.6x | P/E 2025 | 89.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.45B 518M 463M 428M 388M 726M 49.24B 737M 5.15B 2.04B 25.75B 1.94B 1.9B 81.54B | EV / Sales 2024 |
3.66x | EV / Sales 2025 | 4.3x |
| Free-Float |
33.12% | Yield 2024 |
0.16% | Yield 2025 | 0.23% |
| 1 day | -0.26% | ||
| 1 week | -4.23% | ||
| Current month | -6.78% | ||
| 1 month | -5.41% | ||
| 3 months | +3.22% | ||
| 6 months | -4.82% | ||
| Current year | -10.88% |
| 1 week | 7.41 | 8.09 | |
| 1 month | 7.41 | 8.48 | |
| Current year | 6.63 | 11.02 | |
| 1 year | 6.63 | 11.02 | |
| 3 years | 5.84 | 11.85 | |
| 5 years | 5.84 | 15.17 | |
| 10 years | 5.84 | 15.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ai Guo Shi
CEO | Chief Executive Officer | 62 | 06/04/2022 |
Jin feng Yue
DFI | Director of Finance/CFO | - | 02/12/2022 |
Li Jun Wu
PRN | Corporate Officer/Principal | 52 | 01/02/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Wen Bo Su
CHM | Chairman | 60 | 08/05/2014 |
Ai Guo Shi
CHM | Chairman | 62 | 30/06/2017 |
Zhi Jun Liu
BRD | Director/Board Member | 54 | 12/04/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.26% | -4.23% | -14.54% | -19.20% | 589M | ||
| +0.45% | +3.13% | +54.96% | +125.16% | 1,140B | ||
| +0.94% | +4.93% | +39.86% | +78.72% | 641B | ||
| +0.39% | +1.44% | +25.77% | +97.48% | 507B | ||
| -0.05% | +1.67% | +48.24% | +66.73% | 383B | ||
| -3.21% | -2.10% | +60.72% | +33.22% | 347B | ||
| +1.77% | +2.58% | +25.79% | +54.92% | 293B | ||
| +0.31% | +2.31% | +2.90% | +27.52% | 266B | ||
| +1.22% | +4.63% | +52.40% | +64.85% | 240B | ||
| +1.70% | +3.67% | +31.21% | +102.15% | 197B | ||
| Average | +0.29% | +2.28% | +32.73% | +63.16% | 401.44B | |
| Weighted average by Cap. | +0.45% | +2.98% | +41.81% | +84.38% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 980M 147M 131M 122M 110M 206M 13.98B 209M 1.46B 579M 7.31B 551M 540M 23.15B | 916M 137M 123M 114M 103M 192M 13.05B 196M 1.37B 540M 6.83B 515M 504M 21.62B |
| Net income | 60.07M 9M 8.05M 7.45M 6.74M 12.62M 857M 12.83M 89.63M 35.45M 448M 33.79M 33.07M 1.42B | 49.21M 7.37M 6.59M 6.1M 5.52M 10.34M 702M 10.51M 73.42M 29.04M 367M 27.68M 27.09M 1.16B |
| Net Debt | -357M -53.52M -47.86M -44.28M -40.09M -75.03M -5.09B -76.26M -533M -211M -2.66B -201M -197M -8.43B | -479M -71.79M -64.19M -59.39M -53.77M -101M -6.83B -102M -715M -283M -3.57B -269M -264M -11.31B |
Employees
1,332
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/10/26 | CNY 7.700 | -0.26% | 3,244,900 |
| 23/10/26 | CNY 7.720 | +0.13% | 4,436,999 |
| 22/10/26 | CNY 7.710 | -2.41% | 2,692,405 |
| 21/10/26 | CNY 7.900 | -1.00% | 3,685,578 |
| 20/10/26 | CNY 7.980 | -0.75% | 2,702,500 |
- Stock Market
- Stocks
- 002644 Stock
Select your edition
All financial news and data tailored to specific country editions
















